Abbott Laboratories (ABT)vsMonster Beverage Corp (MNST)
ABT
Abbott Laboratories
$84.32
-3.09%
HEALTHCARE · Cap: $151.56B
MNST
Monster Beverage Corp
$86.29
+13.58%
CONSUMER DEFENSIVE · Cap: $84.38B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 444% more annual revenue ($45.13B vs $8.29B). MNST leads profitability with a 23.0% profit margin vs 13.9%. ABT appears more attractively valued with a PEG of 1.29. MNST earns a higher WallStSmart Score of 68/100 (B-).
ABT
Buy56
out of 100
Grade: C
MNST
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+3.7%
Fair Value
$87.55
Current Price
$84.32
$3.23 discount
Margin of Safety
+70.6%
Fair Value
$274.97
Current Price
$86.29
$188.68 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 31.3%
Earnings expanding 66.6% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 27 in profit
Keeps 23 of every $100 in revenue as profit
Areas to Watch
Weak financial health signals
Earnings declined 19.7%
Expensive relative to growth rate
Trading at 10.2x book value
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bull Case : MNST
The strongest argument for MNST centers on Operating Margin, EPS Growth, Altman Z-Score. Profitability is solid with margins at 23.0% and operating margin at 31.3%. Revenue growth of 17.6% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are Piotroski F-Score, EPS Growth.
Bear Case : MNST
The primary concerns for MNST are PEG Ratio, Price/Book, P/E Ratio. A P/E of 41.7x leaves little room for execution misses.
Key Dynamics to Monitor
ABT profiles as a value stock while MNST is a growth play — different risk/reward profiles.
ABT carries more volatility with a beta of 0.65 — expect wider price swings.
MNST is growing revenue faster at 17.6% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
MNST scores higher overall (68/100 vs 56/100), backed by strong 23.0% margins and 17.6% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Monster Beverage Corp
CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA
Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless and Burn.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?